Phase 1 study in malaria naı¨ve adults of bsam2/ alhydrogel h + cpg 7909, a blood stage vaccine against p. falciparum malaria

HIGHLIGHTS

• who: Ruth D. Ellis et al. from the ¤b Current address: Novartis Vaccines Institute for Global Health, Siena, Italy have published the Article: Phase 1 Study in Malaria Naı¨ve Adults of BSAM2/ Alhydrogel H + CPG 7909, a Blood Stage Vaccine against P. falciparum Malaria, in the Journal: PLOS ONE | www.plosone.org of April/26,/2012
• what: The aim of this study was to assess safety and reactogenicity of BSAM2/AlhydrogelH+CPG 7909 in malarianaïve the authors adults. While cellular responses were not analyzed in this study, careful formulation and use of adjuvants . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.